subject: CHEBI:94531

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: primary central nervous system Hodgkin lymphoma

tested_intervention: unsure


subject: CHEBI:52717


subject: CHEBI:6456

subject_name: Lidocaine

object_name: neuroma

tested_intervention: yes


subject: CHEBI:184381

subject_name: Bacitracin

object_name: Arrhythmia


subject: CHEBI:3534

subject_name: Cephalexin


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Postoperative endophthalmitis


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Advanced cancer


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: HER2 positive breast carcinoma


subject: UNII:GKF8S4C432

object_name: Early Stage Breast Carcinoma


subject: UNII:GKF8S4C432

object_name: Locally advanced breast cancer


subject: UNII:GKF8S4C432

object_name: breast neoplasm


subject: UNII:GKF8S4C432

object_name: hormone receptor negative tumor


subject: UNII:GKF8S4C432

object_name: Hormone receptor positive tumor


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: GTOPDB:13790

subject_name: benmelstobart


subject: GTOPDB:13790

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:13790


subject: GTOPDB:13790

object_name: triple-negative breast carcinoma


subject: GTOPDB:13790


subject: GTOPDB:13790


subject: GTOPDB:13790


subject: GTOPDB:13790


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib


subject: UNII:5ZHA5P4PFX


subject: UNII:5ZHA5P4PFX


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UNII:768FW21J3L


subject: UNII:768FW21J3L


subject: UNII:768FW21J3L


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: CHEBI:5523

subject_name: Goserelin


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13396

object_name: breast carcinoma


subject: GTOPDB:13396

object_name: breast cancer


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5907918

subject_name: Anti-PD-1/Anti-VEGF Bispecific Antibody JS207


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5907918


subject: UMLS:C5783522

subject_name: Anti-HER2 Antibody-drug Conjugate JSKN003


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C5783522


subject: UMLS:C0115922

subject_name: endogenous pyrogen


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: UMLS:C0115922


subject: PR:000059798

subject_name: ciliary microtubule-associated protein 2


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: PR:000059798


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5418043


subject: UMLS:C5418043


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5854521

subject_name: Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102


subject: UMLS:C5854521


subject: UMLS:C5854521


subject: UMLS:C5854521


subject: UMLS:C5854521


subject: UMLS:C5854521


subject: UMLS:C5667074

subject_name: Anti-PD-1/Anti-TGF-beta Bifunctional Fusion Protein TQB2868


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UMLS:C5667074


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: obesity


subject: UNII:P6YC3EG204

object_name: Overweight and obesity


subject: UNII:P6YC3EG204

object_name: glucose intolerance


subject: UNII:P6YC3EG204

object_name: Glucose Intolerance, CTCAE


subject: UNII:P6YC3EG204

object_name: Drug action (disorder)


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: CHEBI:15982


subject: CHEBI:15982


subject: CHEBI:15982


subject: CHEBI:15982


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UNII:WTT295HSY5

subject_name: Dulaglutide


subject: UNII:WTT295HSY5


subject: UNII:WTT295HSY5


subject: UNII:WTT295HSY5


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: UNII:IK88NC17OD

object_name: severe early-childhood-onset retinal dystrophy


subject: UNII:KE3U2023NP

subject_name: Poractant alfa

object_name: congenital heart disease


subject: UNII:KE3U2023NP

object_name: hypoplastic left heart syndrome


subject: UMLS:C1832030

object_name: malignant pleural mesothelioma


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: hepatitis C


subject: CHEBI:15765

subject_name: Levodopa

object_name: Restless legs


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: respiratory syncytial virus bronchiolitis


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: small cell carcinoma


subject: UNII:4T36H88UA7

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL4298001


subject: CHEMBL.COMPOUND:CHEMBL4298001


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UNII:3HP012Q0FH

object_name: Macular Edema


subject: UNII:3HP012Q0FH

object_name: retinal disease


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UNII:2H1PA8H1EN


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: Rheumatism


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: trigeminal neuralgia


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: ureter neoplasm


subject: PUBCHEM.COMPOUND:21874242

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:21874242

object_name: kidney cancer


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: inherited lipid metabolism disorder


subject: DRUGBANK:DB10640

object_name: Dyslipidemia


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: Behcet disease


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Hypercholesterolemia


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:32599

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:32599

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:32599

object_name: Hyper IgE


subject: CHEBI:82941

subject_name: Fosamprenavir

object_name: HCV coinfection


subject: CHEBI:82941

object_name: Chronic HIV infection


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Crohn disease


subject: CHEBI:145158

object_name: adult acute myeloid leukemia


subject: CHEBI:145158

object_name: childhood acute myeloid leukemia


subject: CHEBI:145158

object_name: acute myeloid leukemia


subject: GTOPDB:8221

subject_name: epacadostat

object_name: type C thymoma


subject: GTOPDB:8221

object_name: thymus neoplasm


subject: GTOPDB:8221

object_name: thymus cancer


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C0722196

subject_name: Nutropin AQ

object_name: Prader-Willi syndrome


subject: UMLS:C0070286

subject_name: pentaglobulin

object_name: septic shock


subject: UNII:464OXX39Y6

subject_name: Dinalbuphine sebacate

object_name: cholecystitis


subject: UNII:464OXX39Y6

object_name: Cholecystitis, CTCAE 3.0


subject: UNII:464OXX39Y6

object_name: Cholecystitis, CTCAE 5.0


subject: UNII:464OXX39Y6

object_name: outcomes general quality of life


subject: UNII:464OXX39Y6

object_name: Perceived quality of life


subject: UNII:464OXX39Y6

object_name: Good quality of life


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Refractory status epilepticus


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: social phobia


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:134689

subject_name: Rucaparib

object_name: esophageal adenocarcinoma


subject: CHEBI:134689

object_name: gastric adenocarcinoma


subject: CHEBI:134689


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4026

object_name: Adenocarcinoma gastric recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UMLS:C0758290

subject_name: IRX 2

object_name: Metastatic gastric adenocarcinoma


subject: UMLS:C0758290

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: UMLS:C0758290

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C0758290

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UMLS:C0758290

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: UMLS:C0758290

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UMLS:C0758290

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: UMLS:C0758290

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Recurrent Gastroesophageal Junction Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Adenocarcinoma gastric recurrent


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: contrast-induced nephropathy


subject: CHEBI:7986

object_name: diabetes mellitus


subject: UNII:97I1C92E55

subject_name: CEFIXIME

object_name: urinary tract infection


subject: UNII:97I1C92E55

object_name: bacterial urinary tract infection


subject: UNII:97I1C92E55

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:472657

subject_name: Cefixime


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:4911

subject_name: Etoposide

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4724802


subject: PR:000014047

subject_name: eosinophil cationic protein

object_name: mycosis fungoides


subject: PR:000014047

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: PR:000014047

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: cancer


subject: CHEBI:17061

object_name: neoplasm


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: UNII:70FJN2AW22

object_name: Hepatic impairment


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680


subject: CHEBI:91872

object_name: Neck Carcinoma


subject: CHEBI:91872

object_name: head and neck neoplasm


subject: CHEBI:91872

object_name: head and neck cancer


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: GTOPDB:13450

subject_name: briquilimab

object_name: chronic idiopathic urticaria


subject: UNII:QWX84D0DRC

subject_name: BRIQUILIMAB


subject: UMLS:C5418059

subject_name: AMG 191


subject: UMLS:C5206716

object_name: head and neck squamous cell carcinoma


subject: CHEBI:2453

subject_name: Acyclovir

object_name: ulcer disease


subject: CHEBI:28496

subject_name: ACV tripeptide


subject: CHEBI:28496

object_name: genital herpes


subject: CHEBI:28496

object_name: Genital herpes male


subject: CHEBI:28496

object_name: genital herpes in women


subject: CHEBI:71015

subject_name: perampanel hydrate

object_name: neuropathy, small fiber


subject: CHEBI:71015

object_name: primary erythermalgia


subject: CHEBI:71013

subject_name: Perampanel


subject: CHEBI:71013


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Cannabis use disorder


subject: CHEBI:76016

object_name: Neuroses, Anxiety


subject: CHEBI:76016

object_name: Anxiety state


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: cholecystitis


subject: CHEBI:6149

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:6149

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:9927

subject_name: Valsartan

object_name: Hypertension stage 2


subject: CHEBI:601027

subject_name: Aliskiren


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Chronic anemia


subject: UMLS:C0971122

subject_name: ICL 670A


subject: UMLS:C0971122

object_name: transfusional hemosiderosis


subject: CHEBI:2914

subject_name: Atracurium

object_name: colorectal cancer


subject: CHEBI:2914

object_name: colorectal carcinoma


subject: CHEBI:2914

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:92323


subject: CHEBI:92323


subject: CHEBI:92323


subject: UMLS:C3896863

object_name: bronchial neoplasm


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C5666899

subject_name: Oncolytic Vaccinia Virus PF-07263689

object_name: renal cell adenocarcinoma


subject: UMLS:C5666899

object_name: kidney cancer


subject: UMLS:C5666899

object_name: renal cell carcinoma


subject: UMLS:C5666899

object_name: childhood kidney cell carcinoma


subject: UMLS:C5666899

object_name: squamous cell carcinoma


subject: UMLS:C5666899

object_name: Neck Carcinoma


subject: UMLS:C5666899

object_name: head and neck neoplasm


subject: UMLS:C5666899

object_name: head and neck cancer


subject: UMLS:C5666899

object_name: adult hepatocellular carcinoma


subject: UMLS:C5666899

object_name: liver cancer


subject: UMLS:C5666899

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C5666899

object_name: liver carcinoma


subject: UMLS:C5666899


subject: UMLS:C5666899


subject: UMLS:C5666899


subject: UMLS:C5666899

object_name: ovarian cancer


subject: UMLS:C5666899

object_name: ovarian neoplasm


subject: UMLS:C5666899

object_name: ovarian carcinoma


subject: UMLS:C5666899

object_name: bladder tumor


subject: UMLS:C5666899

object_name: urinary bladder carcinoma


subject: UMLS:C5666899

object_name: urinary bladder cancer


subject: UMLS:C5666899

object_name: childhood bladder carcinoma


subject: UMLS:C5666899

object_name: melanoma


subject: UMLS:C5666899

object_name: malignant soft tissue neoplasm


subject: UMLS:C5666899

object_name: sarcoma


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB

object_name: childhood kidney cell carcinoma


subject: UNII:LZZ0IC2EWP

object_name: squamous cell carcinoma


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Multiple rib fractures


subject: PR:000014391

object_name: coronary artery disorder


subject: PR:000014391

object_name: coronary atherosclerosis


subject: PR:000017598

subject_name: endoribonuclease ZC3H12A


subject: PR:000017598


subject: PUBCHEM.COMPOUND:11422859

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: Infant Acute Biphenotypic Leukemia


subject: UMLS:C5544403

subject_name: Secretome

object_name: epilepsy


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Q wave MI


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: DRUGBANK:DB18554

object_name: disorder of glycogen metabolism


subject: UMLS:C2699920

subject_name: Tetanus-CMV Fusion Peptide Vaccine

object_name: cytomegalovirus infection


subject: UMLS:C2699920

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C2699920


subject: UMLS:C2699920

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C2699920

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C2699920

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2699920

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C2699920

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C2699920

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C2699920

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C2699920

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C2699920

object_name: MALT lymphoma


subject: UMLS:C2699920

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UMLS:C2699920

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C2699920

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C2699920

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C2699920

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: UMLS:C2699920

object_name: adult nodular lymphocyte predominant Hodgkin lymphoma


subject: UMLS:C2699920

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: UMLS:C2699920

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: UMLS:C2699920

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C2699920

object_name: central nervous system non-hodgkin lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UMLS:C2699920

object_name: primary central nervous system Hodgkin lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2699920

object_name: solitary osseous plasmacytoma


subject: UMLS:C2699920

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C2699920

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C2699920

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UMLS:C2699920

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C2699920

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C2699920

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C2699920

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C2699920

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C2699920

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C2699920

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2699920

object_name: anaplastic large cell lymphoma


subject: UMLS:C2699920

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C2699920

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C2699920

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C2699920

object_name: Untreated Hairy Cell Leukemia


subject: UMLS:C2699920

object_name: Mantle cell lymphoma stage I


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C2699920

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UMLS:C2699920

object_name: Secondary Myelodysplastic Syndrome


subject: UMLS:C2699920

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: Mantle cell lymphoma stage III


subject: UMLS:C2699920

object_name: refractory hairy cell leukemia


subject: UMLS:C2699920

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C2699920

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C2699920

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C2699920

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UMLS:C2699920

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C2699920

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2699920

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2699920

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C2699920

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C2699920

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Chronic lymphocytic leukaemia stage 1


subject: UMLS:C2699920

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C2699920

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C2699920

object_name: Chronic lymphocytic leukaemia stage 4


subject: UMLS:C2699920

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C2699920

object_name: Chronic lymphocytic leukaemia stage 2


subject: UMLS:C2699920

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UMLS:C2699920

object_name: B-cell small lymphocytic lymphoma stage I


subject: UMLS:C2699920

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UMLS:C2699920

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C2699920

object_name: Adult Acute Promyelocytic Leukemia


subject: UMLS:C2699920

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C2699920

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C2699920

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C2699920

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C2699920

object_name: essential thrombocythemia


subject: UMLS:C2699920

object_name: extramedullary plasmacytoma


subject: UMLS:C2699920

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C2699920

object_name: chronic myelomonocytic leukemia


subject: UMLS:C2699920

object_name: Stage I Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: Stage I Adult Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C2699920

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C2699920

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: Stage II Adult Hodgkin Lymphoma


subject: UMLS:C2699920

object_name: chronic eosinophilic leukemia


subject: UMLS:C2699920

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C2699920

object_name: Plasma cell myeloma refractory


subject: UMLS:C2699920

object_name: DS Stage I Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: ISS Stage I Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: ISS Stage III Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: prolymphocytic leukemia


subject: UMLS:C2699920

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: ISS Stage II Plasma Cell Myeloma


subject: UMLS:C2699920

object_name: acquired polycythemia vera


subject: UMLS:C2699920

object_name: myelofibrosis


subject: CHEBI:15940

subject_name: Niacin

object_name: myocardial ischemia


subject: CHEBI:17154

subject_name: Nicotinamide


subject: UMLS:C3488450

subject_name: Viscum album whole extract

object_name: Childhood Breast Carcinoma


subject: UMLS:C3488450

object_name: breast carcinoma


subject: UMLS:C3488450

object_name: breast cancer


subject: UMLS:C3488450

object_name: triple-negative breast carcinoma


subject: UMLS:C3488450

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: alcohol abuse


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: prostate neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:ASU841TV0X

subject_name: Veledimex

object_name: scleroderma


subject: UNII:ASU841TV0X

object_name: systemic sclerosis


subject: UNII:ASU841TV0X

object_name: localized scleroderma


subject: UNII:ASU841TV0X

object_name: Morphea


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: complete trisomy 21


subject: UNII:JSV288Q5CV

object_name: Down syndrome


subject: CHEBI:135207

subject_name: Clofedanol

object_name: brain ischemia


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:85989

subject_name: Avycaz

object_name: Abdominal Infection


subject: CHEBI:85989

object_name: ventilator-associated pneumonia


subject: CHEBI:85989

object_name: urinary tract infection


subject: CHEBI:85989

object_name: bacterial urinary tract infection


subject: CHEBI:85989

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:85989

object_name: acute pyelonephritis


subject: CHEBI:85989

object_name: bacteriemia


subject: CHEBI:85989

object_name: Bacteremia, CTCAE


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UNII:A6U64OU57E

subject_name: Lanraplenib

object_name: acute myeloid leukemia by FAB classification


subject: UNII:A6U64OU57E

object_name: acute myeloid leukemia


subject: UNII:A6U64OU57E

object_name: Refractory acute myeloid leukemia


subject: GTOPDB:13850

subject_name: ifinatamab deruxtecan

object_name: Prostatic Cancer, Castration-Resistant


subject: GTOPDB:13850

object_name: Embolism, Tumor


subject: GTOPDB:13850

object_name: Neoplasm Metastasis


subject: GTOPDB:13850

object_name: Metastasis


subject: GTOPDB:13850

object_name: Metastatic Lesion


subject: UNII:C6I0GC0GX5

subject_name: IFINATAMAB DERUXTECAN


subject: UNII:C6I0GC0GX5


subject: UNII:C6I0GC0GX5


subject: UNII:C6I0GC0GX5


subject: UNII:C6I0GC0GX5


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: CHEBI:132922

object_name: cesarean section; complications


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C3641720

object_name: neoplasm


subject: UNII:38VAG2SA33

subject_name: Pagoclone

object_name: stuttering


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Spinal anesthetics causing adverse effects in therapeutic use


subject: CHEBI:8404

subject_name: Prilocaine


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: glycogen storage disease II


subject: CHEBI:193137

object_name: Childhood Breast Carcinoma


subject: CHEBI:193137

object_name: breast carcinoma


subject: CHEBI:193137

object_name: breast cancer


subject: UMLS:C2984020


subject: UMLS:C2984020


subject: UMLS:C2984020


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: anus cancer


subject: UNII:YZS3R7LP44

object_name: anal carcinoma


subject: UNII:YZS3R7LP44

object_name: liver cancer


subject: UNII:YZS3R7LP44

object_name: liver neoplasm


subject: UNII:YZS3R7LP44

object_name: Adult Liver Carcinoma


subject: UNII:YZS3R7LP44

object_name: liver carcinoma


subject: UNII:YZS3R7LP44

object_name: peritoneum cancer


subject: UNII:YZS3R7LP44

object_name: pancreatic neoplasm


subject: UNII:YZS3R7LP44

object_name: exocrine pancreatic carcinoma


subject: UNII:YZS3R7LP44

object_name: malignant pancreatic neoplasm


subject: UNII:YZS3R7LP44

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: gallbladder cancer


subject: UNII:YZS3R7LP44

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: gallbladder carcinoma


subject: UNII:YZS3R7LP44

object_name: small intestine cancer


subject: UNII:YZS3R7LP44

object_name: small intestine carcinoma


subject: UNII:YZS3R7LP44

object_name: extrahepatic bile duct carcinoma


subject: UNII:YZS3R7LP44

object_name: malignant tumor of extrahepatic bile duct


subject: UNII:YZS3R7LP44

object_name: Gastrointestinal Carcinoid Tumor


subject: UNII:YZS3R7LP44

object_name: appendix carcinoma


subject: UMLS:C3502118

subject_name: triomune

object_name: AIDS


subject: UNII:TWQ8K8A81Y

subject_name: Larotaxel

object_name: cancer


subject: UNII:TWQ8K8A81Y

object_name: neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Sicca Syndrome


subject: CHEBI:177783

subject_name: Eniluracil

object_name: Recurrent Rectal Cancer


subject: CHEBI:177783

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:177783

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:177783

object_name: Rectal cancer stage IV


subject: CHEBI:177783

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:177783

object_name: Colon cancer recurrent


subject: CHEBI:177783

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:177783

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:177783

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:177783

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:177783

object_name: rectum adenocarcinoma


subject: CHEBI:177783

object_name: colon adenocarcinoma


subject: UMLS:C5909995

subject_name: Autologous Total Tumor mRNA Loaded Liposome Vaccine

object_name: melanoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Coronavinae infectious disease


subject: UMLS:C4726002

object_name: Human Papillomavirus-16 Positive


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Caesarean section


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Dyslipidemia


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: Inflammation


subject: UNII:29DKI2H2NY

subject_name: Tinostamustine


subject: CHEBI:23044

subject_name: carotenoid

object_name: retinal disease


subject: CHEBI:35147

subject_name: alpha-Carotene


subject: CHEBI:32040

subject_name: Pranoprofen


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Control of hip fracture risk


subject: UMLS:C0770246

object_name: hip fracture


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Congenital IGHD


subject: CHEBI:73604

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C5854464

subject_name: BTK Degrader ABBV-101

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5854464

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: small cell lung carcinoma


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Venous occlusion


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: IgA Nephropathy


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C3537161

subject_name: Dipeptidyl Peptidase 4 Inhibitor [EPC]

object_name: short bowel syndrome


subject: UMLS:C3537225

subject_name: Dipeptidyl Peptidase-4 Inhibitor


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: HER2-positive gastric cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:46874763

object_name: penicillin allergy


subject: PUBCHEM.COMPOUND:46874763

object_name: Allergy to penicillin


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0759338

object_name: squamous cell carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: acute myeloid leukemia


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: pulmonary hypertension, primary, 1


subject: UNII:YB18NF020M

object_name: pulmonary hypertension


subject: UNII:YB18NF020M

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:YB18NF020M

object_name: pulmonary arterial hypertension


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: granulomatous mastitis


subject: UNII:2946IE3VYD

object_name: pancreatic ductal adenocarcinoma


subject: MESH:D016827

subject_name: CD8 Antigens


subject: PR:000001828

subject_name: NKG2-D type II integral membrane protein


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: Allergic skin reaction


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Erythropoietin adverse reaction


subject: CHEBI:15365

subject_name: Aspirin


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: UMLS:C2987409


subject: CHEBI:4911

subject_name: Etoposide

object_name: localized osteosarcoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:G8RGG88B68

object_name: Metastatic osteosarcoma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:25681

object_name: Fatigue


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: cancer


subject: UMLS:C3536908

object_name: neoplasm


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3853047

subject_name: Transmucosal Oral Fentanyl Citrate

object_name: Breakthrough pain


subject: CHEBI:3423

subject_name: Carmustine

object_name: glioma


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: nasopharyngeal carcinoma


subject: CHEBI:50847

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5234969

subject_name: Cam

object_name: Osteoarthritis of glenohumeral joint


subject: UMLS:C0678112

subject_name: CAM brand of Ephedrine Hydrochloride


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UniProtKB:P62158

subject_name: Calmodulin 1


subject: UniProtKB:P0DP23

subject_name: CALM1_HUMAN Calmodulin-1 (sprot)


subject: UMLS:C0007578

subject_name: Cell Adhesion Molecules


subject: UniProtKB:P0DP29

subject_name: CALM1_RAT Calmodulin-1 (sprot)


subject: PR:000049739

subject_name: calmodulin (rat)


subject: UniProtKB:P62157

subject_name: CALM_BOVIN Calmodulin (sprot)


subject: PR:000004978

subject_name: calmodulin


subject: PR:000007971

subject_name: somatoliberin

object_name: Congenital IGHD


subject: PR:000007971

object_name: Reduced circulating growth hormone concentration


subject: CHEBI:74224

object_name: Stage I Carcinoma of Bladder


subject: CHEBI:74224

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: CHEBI:74224

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:74224

object_name: Bladder cancer recurrent


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: colon cancer liver metastasis


subject: UMLS:C0723595

subject_name: Tace


subject: DRUGBANK:DB13975

subject_name: Black cohosh

object_name: ductal breast carcinoma in situ


subject: UMLS:C1176287

subject_name: Cimicifuga racemosa, flower essences


subject: UMLS:C0009905

subject_name: Contraceptives, Oral

object_name: Metrorrhagia


subject: UMLS:C0009905

object_name: Break-through bleeding (finding)


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: acute undifferentiated leukemia


subject: GTOPDB:4934

subject_name: G-CSF


subject: CHEMBL.COMPOUND:CHEMBL5095381

subject_name: RECATICIMAB

object_name: stroke disorder


subject: CHEMBL.COMPOUND:CHEMBL5095381

object_name: cerebrovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL5095381

object_name: Stroke (heart beat)


subject: CHEMBL.COMPOUND:CHEMBL5095381

object_name: Stroke, CTCAE


subject: UMLS:C5446789

subject_name: Recaticimab


subject: UMLS:C5446789


subject: UMLS:C5446789


subject: UMLS:C5446789


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)


subject: UMLS:C0279328

object_name: respiratory failure


subject: UMLS:C0279328

object_name: acute respiratory failure


subject: UMLS:C0279328

object_name: severe acute respiratory syndrome


subject: UMLS:C0279328

object_name: acute respiratory distress syndrome


subject: UMLS:C0279328

object_name: cytokine release syndrome


subject: UMLS:C0279328

object_name: Cytokine storm


subject: UMLS:C2930857

object_name: HIV-1 infection


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: tropical spastic paraparesis


subject: MESH:D014862

subject_name: Wasp Venoms

object_name: Allergy


subject: MESH:D014862

object_name: History of allergies


subject: PUBCHEM.COMPOUND:53400847

subject_name: Gosogliptin

object_name: type 2 diabetes mellitus


subject: CHEBI:31759

subject_name: Lafutidine

object_name: Erosive esophagitis


subject: UNII:760I9WM792

subject_name: Lasmiditan

object_name: Transformed migraine


subject: UNII:760I9WM792

object_name: Common Migraine


subject: UMLS:C1517132

subject_name: Farnesyl Transferase Inhibitor

object_name: cystic fibrosis


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: Neonatal Early-Onset Sepsis


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:2956

subject_name: Azlocillin


subject: CHEBI:599928

subject_name: Latamoxef


subject: CHEBI:6770

subject_name: MEROPENEM


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: Overweight and obesity


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: UNII:DTI67O9503

subject_name: Alglucosidase alfa

object_name: disorder of glycogen metabolism


subject: UMLS:C3896895

subject_name: Anti-MUC1 Monoclonal Antibody BTH1704

object_name: pancreatic neoplasm


subject: UMLS:C3896895

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3896895

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB17468

subject_name: Odetiglucan


subject: DRUGBANK:DB17468


subject: DRUGBANK:DB17468


subject: UMLS:C2698691

subject_name: Imprime PGG


subject: UMLS:C2698691


subject: UMLS:C2698691


subject: CHEBI:5134

subject_name: Fluticasone

object_name: esophagitis


subject: CHEBI:5134

object_name: Esophagitis, CTCAE


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: UNII:52CMI0WC3Y

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:17026

subject_name: Progesterone

object_name: Unwanted pregnancy


subject: CHEBI:478164

subject_name: Cefepime

object_name: cesarean section; infection


subject: GTOPDB:13768

subject_name: cagrilintide

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL4802169

subject_name: CAGRILINTIDE


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Adult Central Nervous System Neoplasm


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:8378

subject_name: Prednisolone

object_name: urticaria


subject: CHEBI:8378

object_name: reported urticaria (physical finding)


subject: CHEBI:8378

object_name: Urticaria, CTCAE


subject: CHEBI:8378

object_name: Allergy


subject: CHEBI:8378

object_name: History of allergies


subject: CHEBI:8988

object_name: Unresectable Esophageal Adenocarcinoma


subject: CHEBI:8988

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:8988

object_name: Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: Frontal balding


subject: UMLS:C4287745

subject_name: LAM 002A

object_name: Pick Complex


subject: UMLS:C4287745

object_name: frontotemporal dementia


subject: UMLS:C4287745

object_name: Pick disease


subject: UMLS:C0939831

subject_name: Beta vulgaris homeopathic preparation

object_name: mucositis


subject: UMLS:C1619396

subject_name: DEXAMETHASONE, ORAL, 0.25 MG ADMINISTERED

object_name: bronchiolitis


subject: CHEBI:149509

object_name: Primary hypercholesterolemia


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: Vomiting of pregnancy


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Unresectable Undifferentiated Pleomorphic Sarcoma


subject: UNII:DPT0O3T46P

object_name: Malignant fibrous histiocytoma metastatic


subject: UNII:DPT0O3T46P

object_name: Metastatic Dedifferentiated Liposarcoma


subject: UNII:DPT0O3T46P

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:76842

object_name: melanoma


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: breast neoplasm


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:44915

subject_name: Propofol

object_name: renal carcinoma


subject: CHEBI:44915

object_name: kidney cancer


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic hepatocellular carcinoma


subject: CHEBI:31348

object_name: Advanced Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Muscle Invasive Bladder Carcinoma


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: gastroesophageal cancer


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5564736


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Acute myeloid leukemia in remission


subject: CHEBI:93776

object_name: Neoplasm, Residual


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Richter syndrome


subject: UMLS:C3641122


subject: CHEBI:23359

subject_name: colchicine

object_name: ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome


subject: CHEBI:23359

object_name: Adverse Event Associated with Cardiac Arrhythmia


subject: UMLS:C5962616

subject_name: Anti-nectin-4 Antibody-drug Conjugate LY4052031

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5962616

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5962616

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C5962616

object_name: cervical cancer


subject: UMLS:C5962616

object_name: cervical carcinoma


subject: UMLS:C5962616

object_name: carcinoma of esophagus


subject: UMLS:C5962616

object_name: esophageal cancer


subject: UMLS:C5962616

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5962616

object_name: neoplasm of esophagus


subject: UMLS:C5962616

object_name: prostate carcinoma


subject: UMLS:C5962616

object_name: prostate cancer


subject: UMLS:C5962616

object_name: pancreatic neoplasm


subject: UMLS:C5962616

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5962616

object_name: malignant pancreatic neoplasm


subject: UMLS:C5962616

object_name: ovarian cancer


subject: UMLS:C5962616

object_name: ovarian neoplasm


subject: UMLS:C5962616

object_name: ovarian carcinoma


subject: UMLS:C5962616

object_name: bladder tumor


subject: UMLS:C5962616

object_name: urinary bladder carcinoma


subject: UMLS:C5962616

object_name: urinary bladder cancer


subject: UMLS:C5962616

object_name: childhood bladder carcinoma


subject: UMLS:C5962616

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5962616

object_name: renal pelvis carcinoma


subject: UMLS:C5962616

object_name: malignant renal pelvis neoplasm


subject: UMLS:C5962616

object_name: triple-negative breast carcinoma


subject: UMLS:C5962616

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5962616

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:5487426

subject_name: Tiotropium bromide

object_name: Wheezing


subject: PUBCHEM.COMPOUND:5487426

object_name: Wheezing, CTCAE


subject: PUBCHEM.COMPOUND:5487426

object_name: bronchiolitis


subject: PUBCHEM.COMPOUND:5487426

object_name: Asthmatic bronchitis


subject: PUBCHEM.COMPOUND:5487426

object_name: obstructive lung disease


subject: CHEBI:32230

subject_name: tiotropium bromide hydrate


subject: CHEBI:32230


subject: CHEBI:32230


subject: CHEBI:32230


subject: CHEBI:32230


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium


subject: PUBCHEM.COMPOUND:3086655


subject: PUBCHEM.COMPOUND:3086655


subject: PUBCHEM.COMPOUND:3086655


subject: PUBCHEM.COMPOUND:3086655


subject: CHEMBL.COMPOUND:CHEMBL1182657

subject_name: tiotropium bromide


subject: CHEMBL.COMPOUND:CHEMBL1182657


subject: CHEMBL.COMPOUND:CHEMBL1182657


subject: CHEMBL.COMPOUND:CHEMBL1182657


subject: CHEMBL.COMPOUND:CHEMBL1182657


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: PUBCHEM.COMPOUND:11431811


subject: PUBCHEM.COMPOUND:11431811


subject: PUBCHEM.COMPOUND:11431811


subject: PUBCHEM.COMPOUND:11431811


subject: UMLS:C1170135

subject_name: Cathflo Activase

object_name: Pleural effusion


subject: UMLS:C1170135

object_name: Pleural Effusion, CTCAE


subject: UMLS:C1170135

object_name: x-ray of chest: pleural effusion


subject: CHEBI:233309

subject_name: Adagrasib

object_name: metastatic neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:134182831

subject_name: VOCIPROTAFIB


subject: PUBCHEM.COMPOUND:134182831

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:134182831

object_name: Neoplasm Metastasis


subject: UMLS:C5783371

subject_name: Vociprotafib


subject: UMLS:C5783371


subject: UMLS:C5783371


subject: UNII:4685R51V7M

subject_name: Esmirtazapine

object_name: Postmenopausal symptoms


subject: CHEBI:6950

subject_name: Mirtazapine


subject: UMLS:C1509548

subject_name: Rice Flour

object_name: atopic eczema


subject: UMLS:C1714033

subject_name: wheat dextrin

object_name: Constipation


subject: UMLS:C1714033

object_name: Colonic inertia


subject: CHEBI:64073

object_name: hyperlipidemia


subject: CHEBI:64073

object_name: hyperlipoproteinemia


subject: CHEBI:64073

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:64073

object_name: Serum lipids high (finding)


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UMLS:C4287800

subject_name: Defactinib Hydrochloride

object_name: Metastatic Uveal Melanoma


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: CHEBI:205919

subject_name: Clobetasol

object_name: graft versus host disease


subject: CHEBI:205919

object_name: Oral Manifestations


subject: CHEBI:41879

subject_name: Dexamethasone


subject: MESH:D019275

subject_name: Radiopharmaceuticals

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Hot Flashes, CTCAE


subject: CHEBI:60789

object_name: Hot flashes


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: UMLS:C0021665

subject_name: Insulin-Like Growth Factor I

object_name: Phelan-McDermid syndrome


subject: PR:000009182

subject_name: insulin-like growth factor 1


subject: CHEBI:16240

subject_name: Hioxyl

object_name: periodontitis


subject: CHEBI:16240

object_name: Periodontal Pocket


subject: CHEBI:95165

object_name: pancreatic neoplasm


subject: CHEBI:95165

object_name: exocrine pancreatic carcinoma


subject: CHEBI:95165

object_name: malignant pancreatic neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C5554939

subject_name: Becotatug

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5557417

subject_name: Enlonstobart


subject: UMLS:C5959215

subject_name: Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701


subject: CHEBI:132922

object_name: gallbladder disorder


subject: CHEBI:132922

object_name: History of - gallbladder disease


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C0879578

object_name: peritoneum cancer


subject: UNII:55E08EN074

object_name: acute myocardial infarction


subject: UNII:55E08EN074

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Raynaud disease


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: BRAF V600E mutation positive


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: mast cell activation syndrome


subject: CHEBI:5119

subject_name: fluoxetine hydrochloride

object_name: stroke disorder


subject: CHEBI:5119

object_name: cerebrovascular disorder


subject: CHEBI:5119

object_name: Stroke (heart beat)


subject: CHEBI:5119

object_name: Stroke, CTCAE


subject: CHEBI:5119

object_name: CNS disorder


subject: CHEBI:5119

object_name: nervous system disorder


subject: CHEBI:5119

object_name: cerebral infarction


subject: CHEBI:5119

object_name: aneurysm


subject: CHEBI:5119

object_name: brain infarction


subject: CHEBI:5119

object_name: brain ischemia


subject: CHEBI:5119

object_name: brain disorder


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: UNII:N5WBB45U8L

subject_name: TANRUPRUBART

object_name: Guillain-Barre syndrome


subject: UNII:N5WBB45U8L

object_name: Guillain-Barre Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:52943177

object_name: Heart Failure, CTCAE


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: liver cirrhosis


subject: CHEBI:29708

object_name: Dysgeusia, CTCAE


subject: CHEBI:29708

object_name: Parageusia


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: CHEBI:33198


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: CHEBI:231614

subject_name: Nivolumab

object_name: trophoblastic neoplasm


subject: CHEBI:231614

object_name: granulosa cell tumor


subject: CHEBI:231614

object_name: ovarian Sertoli-Leydig cell tumor


subject: CHEBI:231614

object_name: Sertoli-Leydig cell tumor of intermediate differentiation


subject: CHEBI:231614

object_name: Sertoli-Leydig cell tumor


subject: CHEBI:231614

object_name: primitive neuroectodermal tumor


subject: CHEBI:231614

object_name: yolk sac tumor


subject: CHEBI:231614

object_name: adult yolk sac tumor


subject: CHEBI:231614

object_name: testicular yolk sac tumor


subject: CHEBI:231614

object_name: ovarian yolk sac tumor


subject: CHEBI:231614

object_name: vaginal yolk sac tumor


subject: CHEBI:231614

object_name: breast secretory carcinoma


subject: CHEBI:231614

object_name: adrenal gland neoplasm


subject: CHEBI:231614

object_name: fallopian tube neoplasm


subject: CHEBI:231614

object_name: fibrolamellar hepatocellular carcinoma


subject: CHEBI:231614

object_name: gallbladder neoplasm


subject: CHEBI:231614

object_name: vaginal cancer


subject: CHEBI:231614

object_name: vaginal neoplasm


subject: CHEBI:231614

object_name: hemangioblastoma


subject: CHEBI:231614

object_name: urethra neoplasm


subject: CHEBI:231614

object_name: neurofibrosarcoma


subject: CHEBI:231614

object_name: anus neoplasm


subject: CHEBI:231614

object_name: Urachal cancer


subject: CHEBI:231614

object_name: vulva cancer


subject: CHEBI:231614

object_name: vulvar neoplasm


subject: CHEBI:231614

object_name: adult fibrosarcoma


subject: CHEBI:231614

object_name: pediatric fibrosarcoma


subject: UMLS:C2346820

object_name: trophoblastic neoplasm


subject: UMLS:C2346820

object_name: granulosa cell tumor


subject: UMLS:C2346820

object_name: ovarian Sertoli-Leydig cell tumor


subject: UMLS:C2346820

object_name: Sertoli-Leydig cell tumor of intermediate differentiation


subject: UMLS:C2346820

object_name: Sertoli-Leydig cell tumor


subject: UMLS:C2346820

object_name: primitive neuroectodermal tumor


subject: UMLS:C2346820

object_name: yolk sac tumor


subject: UMLS:C2346820

object_name: adult yolk sac tumor


subject: UMLS:C2346820

object_name: testicular yolk sac tumor


subject: UMLS:C2346820

object_name: ovarian yolk sac tumor


subject: UMLS:C2346820

object_name: vaginal yolk sac tumor


subject: UMLS:C2346820

object_name: breast secretory carcinoma


subject: UMLS:C2346820

object_name: adrenal gland neoplasm


subject: UMLS:C2346820

object_name: fallopian tube neoplasm


subject: UMLS:C2346820

object_name: fibrolamellar hepatocellular carcinoma


subject: UMLS:C2346820

object_name: gallbladder neoplasm


subject: UMLS:C2346820

object_name: vaginal cancer


subject: UMLS:C2346820

object_name: vaginal neoplasm


subject: UMLS:C2346820

object_name: hemangioblastoma


subject: UMLS:C2346820

object_name: urethra neoplasm


subject: UMLS:C2346820

object_name: neurofibrosarcoma


subject: UMLS:C2346820

object_name: anus neoplasm


subject: UMLS:C2346820

object_name: Urachal cancer


subject: UMLS:C2346820

object_name: vulva cancer


subject: UMLS:C2346820

object_name: vulvar neoplasm


subject: UMLS:C2346820

object_name: adult fibrosarcoma


subject: UMLS:C2346820

object_name: pediatric fibrosarcoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Peutz-Jeghers syndrome


subject: GTOPDB:9195

subject_name: clazakizumab

object_name: Renal transplant rejection


subject: GTOPDB:9195

object_name: Transplant glomerulopathy - late form


subject: GTOPDB:9195

object_name: Transplant glomerulopathy - early form


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UNII:HOY74VZE0M

subject_name: gadoxetate

object_name: adult hepatocellular carcinoma


subject: UNII:HOY74VZE0M

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: BCLC Stage 0 Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: BCLC Stage A Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: BCLC Stage B Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: BCLC Stage D Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: BCLC Stage C Adult Hepatocellular Carcinoma


subject: UNII:HOY74VZE0M

object_name: Localized Resectable Adult Liver Carcinoma


subject: UNII:HOY74VZE0M

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C0876064

subject_name: Lantus

object_name: Critical Illness


subject: UMLS:C0021641

subject_name: Insulin


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: Myelodysplasia, CTCAE


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: irritable bowel syndrome


subject: UNII:995FT1W541

subject_name: Idronoxil

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: hypophosphatemia


subject: PUBCHEM.COMPOUND:16129616

object_name: Hypophosphatemia, CTCAE


subject: CHEBI:135973

subject_name: Miacalcic


subject: CHEBI:135973


subject: UNII:DF35I47HCM

subject_name: CALCITONIN


subject: UNII:DF35I47HCM


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: chronic hepatitis B virus infection


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C2985546

subject_name: Antibodies, Monoclonal, Humanized


subject: CHEBI:59905

object_name: Atherosclerotic renal artery stenosis


subject: CHEBI:59905

object_name: Renal arterial hypertension


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:18243


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:141969

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:141969

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:141969

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:141969

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:141969

object_name: anaplastic large cell lymphoma


subject: CHEBI:141969

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:141969

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:141969

object_name: MALT lymphoma


subject: CHEBI:141969

object_name: splenic marginal zone lymphoma


subject: CHEBI:141969

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:141969

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:141969

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:141969

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Collapse of thoracic vertebra


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: GTOPDB:5081

subject_name: 4-1BB ligand

object_name: metastatic neoplasm


subject: GTOPDB:5081

object_name: Embolism, Tumor


subject: GTOPDB:5081

object_name: Neoplasm Metastasis


subject: GTOPDB:5081

object_name: Metastatic Lesion


subject: PR:000016489

subject_name: tumor necrosis factor ligand superfamily member 9


subject: PR:000016489


subject: PR:000016489


subject: PR:000016489


subject: UMLS:C0259309

subject_name: TNFSF9 protein


subject: UMLS:C0259309


subject: UMLS:C0259309


subject: UMLS:C0259309


subject: CHEBI:41791

subject_name: calyculin A

object_name: inherited lipid metabolism disorder


subject: CHEBI:41791

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:41791

object_name: obesity


subject: CHEBI:41791

object_name: Obesity, CTCAE


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: colon carcinoma


subject: UNII:16VY3TM7ZO

object_name: colorectal cancer


subject: UNII:16VY3TM7ZO

object_name: colon cancer


subject: PUBCHEM.COMPOUND:148137

subject_name: antineoplaston AS 2-1


subject: PUBCHEM.COMPOUND:148137


subject: PUBCHEM.COMPOUND:148137


subject: UMLS:C0294295


subject: UMLS:C0294295


subject: UMLS:C0294295


subject: CHEBI:135914

subject_name: carperitide


subject: CHEBI:135914


subject: CHEBI:135914


subject: CHEBI:80233

subject_name: Atrial natriuretic peptide


subject: CHEBI:80233


subject: CHEBI:80233


subject: CHEBI:147420

subject_name: ammonium nitrate phosphate


subject: CHEBI:147420


subject: CHEBI:147420


subject: PR:000011374

subject_name: atrial natriuretic factor


subject: PR:000011374


subject: PR:000011374


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2

object_name: nonpapillary renal cell carcinoma


subject: PR:000002112

object_name: clear cell renal carcinoma


subject: PR:000002112

object_name: renal cell adenocarcinoma


subject: PR:000002112

object_name: renal cell carcinoma


subject: PR:000002112

object_name: Metastatic Renal Cell Carcinoma


subject: PR:000002112

object_name: Metastatic Renal Cell Cancer


subject: PR:000002112

object_name: renal carcinoma


subject: PR:000002112

object_name: kidney neoplasm


subject: PR:000002112

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UMLS:C1655276

subject_name: T-KI


subject: UMLS:C1655276


subject: UMLS:C1655276


subject: UMLS:C1655276


subject: UMLS:C1655276


subject: UMLS:C1655276


subject: UMLS:C1655276


subject: CHEBI:151

subject_name: ISOCITRIC ACID


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:151


subject: CHEBI:681569

subject_name: Clofarabine

object_name: lymphoproliferative syndrome


subject: MESH:C089950

subject_name: MF59 oil emulsion

object_name: hepatitis C


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation


subject: UMLS:C0304547

object_name: colorectal carcinoma


subject: UMLS:C0304547

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Recurrent Kidney Wilms Tumor


subject: UNII:2285XW22DR

object_name: Recurrent Childhood Liver Cancer


subject: UNII:2285XW22DR

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UNII:2285XW22DR

object_name: primitive neuroectodermal tumor


subject: UNII:2285XW22DR

object_name: peripheral primitive neuroectodermal tumor


subject: UNII:2285XW22DR

object_name: hepatoblastoma


subject: UNII:2285XW22DR

object_name: Recurrent Retinoblastoma


subject: UNII:2285XW22DR

object_name: Neuroblastoma recurrent


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Skin and subcutaneous tissue bacterial infections


subject: CHEBI:7025

subject_name: Mupirocin


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: myocardial ischemia


subject: CHEBI:83766

subject_name: Olaparib

object_name: esophageal cancer


subject: CHEBI:83766

object_name: Gastroesophageal junction cancer


subject: CHEBI:185135

subject_name: Polyvidone

object_name: neoplasm of esophagus


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UMLS:C5418019

object_name: leukemia


subject: UMLS:C5418019

object_name: childhood leukemia


subject: CHEBI:8988

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:8988

object_name: Recurrent Carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: childhood malignant neoplasm


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227

object_name: Childhood Brain Neoplasm


subject: UMLS:C0013227

object_name: refractory malignant neoplasm


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C5577555

subject_name: Opdualag


subject: UMLS:C5577555


subject: UMLS:C5577555


subject: UMLS:C5577555


subject: UMLS:C5577555

object_name: Childhood Solid Neoplasm


subject: UMLS:C5577555


subject: UNII:P5DKZ70636

subject_name: Paxalisib


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: stroke disorder


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: cerebrovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: Stroke (heart beat)


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: Stroke, CTCAE


subject: UMLS:C0593103

subject_name: Novoseven


subject: UMLS:C0593103


subject: UMLS:C0593103


subject: UMLS:C0593103


subject: UMLS:C5706440

subject_name: Anti-PD-1/Anti-TIM-3 Bispecific Antibody LB1410

object_name: adult lymphoma


subject: UMLS:C5706440

object_name: lymphoma


subject: UMLS:C5706440

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:24687

subject_name: AMYL NITRITE

object_name: Dysphagia


subject: PUBCHEM.COMPOUND:24687

object_name: Dysphagia, CTCAE


subject: PUBCHEM.COMPOUND:24687

object_name: Achalasia


subject: CHEBI:55344

subject_name: Amyl Nitrite


subject: CHEBI:55344


subject: CHEBI:55344


subject: UMLS:C5418009

subject_name: BRAF Inhibitor BGB-3245

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:88249

subject_name: Mirdametinib


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Chagas disease


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Inhalation injury


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: spinal muscular atrophy


subject: CHEBI:8665

object_name: proximal spinal muscular atrophy


subject: CHEBI:8665

object_name: Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


subject: UMLS:C5783893

subject_name: Botanically-derived Agent RH324

object_name: Safety Issues


subject: GTOPDB:12102

subject_name: sibeprenlimab

object_name: IgA Nephropathy


subject: UNII:GHX28QZ7DD

subject_name: SIBEPRENLIMAB


subject: UMLS:C5555484

subject_name: Sibeprenlimab


subject: UMLS:C4733610


subject: UNII:41XGO0VS1U


subject: CHEBI:30145

subject_name: lithium atom

object_name: psychosis


subject: CHEBI:30145

object_name: Nonorganic psychosis


subject: CHEBI:30145

object_name: Psychosis, CTCAE


subject: CHEBI:30145

object_name: Agitation, CTCAE 3.0


subject: CHEBI:30145

object_name: Agitation


subject: CHEBI:30145

object_name: Agitation, CTCAE 5.0


subject: CHEBI:30145

object_name: Alzheimer disease


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: CHEBI:9123

subject_name: Sertraline

object_name: epilepsy


subject: CHEBI:15544

subject_name: Alprostadil

object_name: diabetic kidney disease


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: pain agnosia


subject: CHEBI:31236

object_name: Pain insensitivity


subject: CHEBI:31236

object_name: no feeling or sensation of skin


subject: CHEBI:31236

object_name: Sensory Loss


subject: UMLS:C5848865

subject_name: Cell Therapy [APC]

object_name: Exposure to ionizing radiation


subject: CHEBI:139072

object_name: neuropathy


subject: CHEBI:8614

subject_name: Psilocybin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:74073

subject_name: Ile-Met

object_name: bipolar I disorder


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEMBL.COMPOUND:CHEMBL2108455

subject_name: octocog alfa

object_name: factor VIII measurement


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII


subject: UNII:D87YGH4Z0Q

subject_name: Omacor

object_name: History of myocardial infarction


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: morbid obesity


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: UMLS:C3898588

subject_name: Liposomal Curcumin

object_name: Chronic kidney disease stage 5 on dialysis


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: Advanced breast cancer


subject: UNII:W7KQU075CV

object_name: HIV infection


subject: UMLS:C5908038

subject_name: Anti-TROP-2 Antibody-drug Conjugate HS-20105

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287709

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4287709

object_name: non-Hodgkin lymphoma


subject: UMLS:C4287709

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4287709

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4287709

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4287709

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C4287709

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4287709

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: lung disorder


subject: CHEBI:5801

object_name: History of - respiratory disease


subject: CHEBI:176304

subject_name: Azythromycin

object_name: severe acute respiratory syndrome


subject: CHEBI:176304

object_name: Coronavinae infectious disease


subject: CHEBI:176304


subject: CHEBI:176304


subject: MESH:D010919

subject_name: Placebos

object_name: Sepsis


subject: MESH:D010919

object_name: Sepsis, CTCAE


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: common cold


subject: UMLS:C0910794

object_name: atopy


subject: UMLS:C0910794


subject: UMLS:C0003241

subject_name: Antibodies

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Papulopustular Rosacea


subject: UNII:N5UK68MGDZ

object_name: Erythematotelangiectatic Rosacea


subject: CHEBI:6121

subject_name: Ketamine

object_name: c.surgical procedure; cardiac


subject: CHEBI:49956

subject_name: Xenon

object_name: post-cardiac arrest syndrome


subject: UNII:25CC4N0P8J

subject_name: NALFURAFINE HYDROCHLORIDE

object_name: end stage renal failure


subject: UNII:25CC4N0P8J

object_name: chronic kidney disease


subject: UNII:25CC4N0P8J

object_name: Chronic uremia


subject: CHEBI:136019

subject_name: Nalfurafine


subject: CHEBI:136019


subject: CHEBI:136019


subject: UMLS:C1610428

subject_name: nalfurafine hydrochloride


subject: UMLS:C1610428


subject: UMLS:C1610428


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4053601


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE

object_name: focal dystonia


subject: UMLS:C1541792

subject_name: Kanglaite Injection

object_name: Metastatic non-small cell lung cancer


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: severe acute respiratory syndrome


subject: UNII:1RXS4UE564

object_name: Respiratory Failure, CTCAE


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: inherited lipid metabolism disorder


subject: CHEBI:3387

object_name: Dyslipidemia


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:231594


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:15365

subject_name: Aspirin

object_name: Multiple Pulmonary Nodules


subject: CHEBI:15365

object_name: Former smoker


subject: CHEBI:15365

object_name: Smoker


subject: CHEBI:15365

object_name: Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)


subject: CHEBI:90620

subject_name: Vatalanib

object_name: malignant mesothelioma


subject: UMLS:C0912413

subject_name: PTK 787


subject: CHEBI:90623


subject: UMLS:C1524078


subject: MESH:C000615779

object_name: dietary carcinogenesis


subject: GTOPDB:3711

object_name: metabolic disease


subject: UNII:FS1N52VS3S


subject: UMLS:C1721258


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: Mesothelioma


subject: CHEBI:231605

object_name: mesothelial neoplasm


subject: CHEBI:231605


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585

object_name: triple-negative breast carcinoma


subject: CHEBI:39585

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:39585

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:39585

object_name: clear cell renal carcinoma


subject: CHEBI:39585

object_name: renal cell adenocarcinoma


subject: CHEBI:39585

object_name: renal cell carcinoma


subject: CHEBI:39585

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: rotator cuff syndrome


subject: MESH:D012462

object_name: Rotator cuff tear


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: subarachnoid hemorrhage


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:18463831

subject_name: Cyclophosphamide Cyclophosphamide

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:9554281

subject_name: (-)-Cyclophosphamide


subject: UMLS:C5783126

subject_name: dexAMETHasone nasal


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Chemotherapy induced systolic dysfunction


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: non-small cell squamous lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:177504

subject_name: Butylphthalide


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: ovarian disease


subject: CHEBI:85994

object_name: ovarian epithelial tumor


subject: CHEBI:85994

object_name: female reproductive system neoplasm


subject: CHEBI:85994

object_name: Neoplasm of the genitourinary tract


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:9635

subject_name: Toremifene

object_name: osteoporosis


subject: CHEBI:9635

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:9635

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:9635

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:9635

object_name: Bone fracture


subject: CHEBI:9635

object_name: Fractured


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: atopic eczema


subject: CHEBI:2948

subject_name: Azathioprine

object_name: interstitial lung disease


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61080

subject_name: Romidepsin

object_name: prostate neoplasm


subject: UMLS:C0963679


subject: UMLS:C3644708

subject_name: Kcentra

object_name: Blood Clot


subject: UMLS:C3644708

object_name: thrombosis


subject: UMLS:C3644708

object_name: Thrombosis of blood vessel


subject: CHEBI:6538

subject_name: Loratadine

object_name: atopic conjunctivitis


subject: CHEBI:63580

subject_name: Ribavirin

object_name: portal hypertension


subject: CHEBI:63580

object_name: Portal Hypertension, CTCAE


subject: PR:000022493


subject: PR:000022493


subject: PR:000022493

object_name: Cirrhosis


subject: PR:000022493

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: hepatocellular adenoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Liver Neoplasms, Experimental


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C2346810


subject: UMLS:C2346810

object_name: liver neoplasm


subject: UMLS:C2346810


subject: PUBCHEM.COMPOUND:54580717

subject_name: KARENITECIN

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:54580717

object_name: carcinoma


subject: CHEBI:177492

subject_name: Cositecan


subject: CHEBI:177492


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Turner syndrome


subject: PUBCHEM.COMPOUND:6096882

object_name: Inflammation


subject: PUBCHEM.COMPOUND:6096882

object_name: cardiovascular disorder


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C4759807

subject_name: TSH, alpha Subunit

object_name: thyroid gland carcinoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Light for dates


subject: CHEBI:89324

object_name: preeclampsia


subject: CHEBI:89324

object_name: Fetal Death


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: PR:000009060

subject_name: insulin-like peptide INSL5

object_name: Childhood Acute Promyelocytic Leukemia


subject: PR:000009060

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000013980


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: PR:000023845


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UniProtKB:P0A8V2


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: UMLS:C3890420


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:79068

subject_name: Crocin

object_name: type 2 diabetes mellitus


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: no feeling or sensation of skin


subject: CHEBI:50731

object_name: Sensory Loss


subject: UMLS:C3495652

subject_name: sesame seed extract

object_name: hyperlipidemia


subject: UMLS:C3495652

object_name: hyperlipoproteinemia


subject: UMLS:C3495652

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C3495652

object_name: Serum lipids high (finding)


subject: UMLS:C3495652

object_name: Prediabetes


subject: CHEBI:151315

subject_name: Heparin

object_name: angioedema


subject: KEGG.COMPOUND:C00374


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Nulliparous


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: Dermatitis


subject: GTOPDB:7684

object_name: Genodermatosis


subject: GTOPDB:7684

object_name: skin disorder


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743035


subject: CHEMBL.COMPOUND:CHEMBL1743035


subject: UMLS:C1881890


subject: UMLS:C1881890


subject: UMLS:C1881890


subject: UMLS:C4055105

subject_name: EGFR Antibody

object_name: Stomach cancer


subject: UMLS:C4055105

object_name: gastric cancer


subject: DRUGBANK:DB19270

object_name: Effects of chemotherapy


subject: DRUGBANK:DB19270

object_name: cholangiocarcinoma


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821


subject: UMLS:C2984517


subject: CHEBI:6933

subject_name: Midodrine

object_name: Spinal shock


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:16118

subject_name: Berberine

object_name: hyperglycemia


subject: CHEBI:16118

object_name: Hyperglycemia, CTCAE


subject: CHEBI:16118

object_name: Glucose in blood specimen above reference range


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: dry eye syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:35623

subject_name: anticonvulsant

object_name: bariatric surgery candidate


subject: UMLS:C0003299

subject_name: Antiepileptic Agents


subject: CHEBI:6367

subject_name: Lamotrigine


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C5418043

subject_name: ADC SHR-A1811

object_name: colorectal cancer


subject: UMLS:C5418043

object_name: colorectal carcinoma


subject: UMLS:C5418043

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:39HBQ4A67L

subject_name: Mobocertinib

object_name: kidney failure


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:9150

object_name: emphysema


subject: UMLS:C1963096

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C1963096

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C1963096

object_name: lung large cell carcinoma


subject: UMLS:C1963096

object_name: squamous cell lung carcinoma


subject: UMLS:C1963096

object_name: adenosquamous lung carcinoma


subject: UMLS:C1963096

object_name: lung adenocarcinoma


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Critical Illness


subject: CHEBI:166902


subject: CHEBI:166902

object_name: respiratory failure


subject: CHEBI:166902

object_name: Respiratory Failure, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:9150

object_name: smoldering plasma cell myeloma


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Solid Neoplasm


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: CHEBI:85164


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UMLS:C3827124


subject: CHEBI:71952

subject_name: Dactolisib

object_name: cancer


subject: CHEBI:71952

object_name: neoplasm


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C5237425

subject_name: STING Agonist GSK3745417


subject: UNII:GBW044919E

subject_name: FOSBRETABULIN TROMETHAMINE

object_name: Recurrent ovarian cancer


subject: UNII:GBW044919E

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:GBW044919E

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:100154


subject: PUBCHEM.COMPOUND:100154


subject: PUBCHEM.COMPOUND:100154


subject: CHEBI:28918

subject_name: Epinephrine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:28918

object_name: obesity


subject: CHEBI:28918

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A


subject: PUBCHEM.COMPOUND:16129681


subject: PUBCHEM.COMPOUND:16129681


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: premature ovarian failure 1


subject: CHEBI:8389

object_name: primary ovarian failure


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:23965

subject_name: estradiol


subject: UMLS:C5417968

subject_name: STING Agonist TAK-676

object_name: non-small cell lung carcinoma


subject: UMLS:C5417968

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: metastatic malignant neoplasm in the brain


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: neoplastic meningitis


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C4687432

subject_name: Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM


subject: UMLS:C4687432


subject: CHEBI:53762

object_name: Hypoxemia


subject: CHEBI:53762

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEBI:53762

object_name: Arrhythmia


subject: CHEBI:53762

object_name: lung disorder


subject: CHEBI:53762

object_name: History of - respiratory disease


subject: CHEBI:53762

object_name: Hypercapnia


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:3745

subject_name: clindamycin

object_name: MRSA colonisation


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: head and neck squamous cell carcinoma


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Antibiotic-associated diarrhea


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673

object_name: Clostridium difficile colitis


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: PUBCHEM.COMPOUND:10048892

subject_name: Fcway

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:10048892

object_name: alcohol dependence


subject: UNII:F35FTM8G49

subject_name: FCWAY


subject: UNII:F35FTM8G49


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Refractory Neuroblastoma


subject: CHEBI:41948

object_name: High Risk Neuroblastoma


subject: UMLS:C0282042


subject: UMLS:C0282042

object_name: Neuroblastoma recurrent


subject: UMLS:C0282042


subject: UMLS:C0873140

subject_name: American ginseng root

object_name: Childhood Breast Carcinoma


subject: UMLS:C0873140

object_name: breast carcinoma


subject: UMLS:C0873140

object_name: breast cancer


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: Axial Spondyloarthritis


subject: CHEBI:58097

object_name: anxiety


subject: CHEBI:58097

object_name: anxiety disorder


subject: CHEBI:58097

object_name: Anxiety symptoms


subject: CHEBI:58097

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:58097

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:58097

object_name: Depressed mood


subject: CHEBI:58097

object_name: Cancer patients and suicide and depression


subject: CHEBI:58097

object_name: Depressed - symptom


subject: CHEBI:58097

object_name: Depression, CTCAE


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Chronic low back pain


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852

object_name: intervertebral disk degenerative disorder


subject: CHEBI:7852

object_name: lumbar disk degenerative disorder


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: Surgical Wound Infection


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:75958

subject_name: solution

object_name: Burn injury


subject: UMLS:C0037633

subject_name: Solutions